FDA Inspection 1235874 — OneBlood Inc
The FDA completed an inspection of OneBlood Inc on Apr 10, 2024 in Greensboro, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 10, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Greensboro, NC (United States)